| |
| | Joined: Nov 2009 Posts: 92 Supporting Member (50+ posts) | OP  Supporting Member (50+ posts)
Joined: Nov 2009 Posts: 92 | It came up in a search. Any takers?
- Pam
44 at 10-26-2009 Dx; SCC, T2N2b, St.IV BOT; Rt. Tonsil out; PET 11-12-09 (3 spots); 3 rds Cisplatin, Taxotere and 5-FU started 11-19-09; PEG 12-24-09; 7 wks chemo-rads done 03-16-10. 06-28 CT/PET watching 1 node; PEG out; 11-15 CT - larger; 11-23 PET activity up; mrdc 12-21; 04-01-11 CLEAN SCANS! ; March 2018 new SCC - Meet with surgeon 4-4-18
| | | | | Joined: Mar 2002 Posts: 4,918 Likes: 65 OCF Founder Patient Advocate (old timer, 2000 posts) | | OCF Founder Patient Advocate (old timer, 2000 posts)
Joined: Mar 2002 Posts: 4,918 Likes: 65 | This has only been tried in mice, and to other researchers considered questionable given what we know about the cellular dna damage to radiated cells.
The path from idea to petri dish, to small animal models, to MAYBE a human clinical trial if someone is interested in putting up the millions of dollars to actually do it, and then the unknown end result of several expensive years of that trial, followed by the too often thumbs down from the FDA, make this idea something way into the future if ever a real viable patient option. So given all that, remember this has only been done in a preliminary mouse model to date.
Brian, stage 4 oral cancer survivor. OCF Founder and Director. The first responsibility of a leader is to define reality. The last is to say thank you. In between, the leader is a servant.
| | |
| Forums23 Topics18,245 Posts197,129 Members13,316 | | Most Online1,788
Jan 23rd, 2025 | | |
|
| |
